Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Whatever happens to the "sealed" agreement with the J3

Anyone still believe that there is potential future revenue to be derived from the J3 lawsuit?

I remember that the resolution of it at the time had us all scratching our heads as to why PTSC/TPL did not come out of the wrangling with a huge win.

There was speculation that that the outcome of the case was conditionally associated with the recertification of the 336.

I, for one, want to see royalties of some kind this time around. It is simply impossible to value the stock of PTSC properly if you don't know what the revenue stream is too look like in any way, shape, or form.

I also wonder how out of the closet the news is at this point. Clearly, the last few days have been insiders and people like us who have followed the company for years. for that matter, how many of us are there really left...

Point being that it is going to take a ton of volume and interest to get the stock up to the levels that we all hope for and it ain't 2006 anymore in terms of wild penny stock speculation.

Finally, we are dilluted worse than a screwdriver at a Las Vegas casino. It is unfortunate that PTSC did not spend their capital during these down times to repurchase their stock and reduce the float. Announcing a real buyback plan based on a percentage of settlement dollars that puts a dent in the # of OS share would be a worthwhile effort, IMO.

For disclosure. Owner of 371k shares @ .38 cost basis. Started accumulating in 2006. Have followed the board and watched the good, bad, and ugly. Have met David Pohl, Jim Turley. Never met Rick. Simply stating so no one thinks I am a newbie to this soap opera.

Share
New Message
Please login to post a reply